These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 2732120)
21. BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000). Gordon KA; Pfaller MA; Jones RN; J Antimicrob Chemother; 2002 May; 49(5):851-5. PubMed ID: 12003983 [TBL] [Abstract][Full Text] [Related]
22. In-vitro activity of PD 131628, a new quinolone antimicrobial agent. Cooper MA; Andrews JM; Wise R J Antimicrob Chemother; 1992 May; 29(5):519-27. PubMed ID: 1320603 [TBL] [Abstract][Full Text] [Related]
23. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones. Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237 [TBL] [Abstract][Full Text] [Related]
24. In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients. Rolston KV; Frisbee-Hume S; LeBlanc B; Streeter H; Ho DH Diagn Microbiol Infect Dis; 2003 Oct; 47(2):441-9. PubMed ID: 14522520 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients. Rolston KV; Frisbee-Hume S; LeBlanc BM; Streeter H; Ho DH Diagn Microbiol Infect Dis; 2002 Oct; 44(2):187-94. PubMed ID: 12458127 [TBL] [Abstract][Full Text] [Related]
26. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone]. Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871 [TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria. Sedlock DM; Dobson RA; Deuel DM; Lesher GY; Rake JB Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163 [TBL] [Abstract][Full Text] [Related]
29. Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina. Lopez H; Stepanik D; Vilches V; Scarano S; Sarachian B; Mikaelian G; Finlay J; Sucari A Diagn Microbiol Infect Dis; 2001 Aug; 40(4):187-92. PubMed ID: 11576792 [TBL] [Abstract][Full Text] [Related]
30. In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria. Cohen MA; Huband MD; Mailloux GB; Yoder SL; Roland GE; Heifetz CL Diagn Microbiol Infect Dis; 1991; 14(5):403-15. PubMed ID: 1665775 [TBL] [Abstract][Full Text] [Related]
31. In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients. Rolston KV; Alvarez ME; Hoy JF; Alderman HC; Ho DH; Bodey GP J Antimicrob Chemother; 1986 Aug; 18(2):159-62. PubMed ID: 3093447 [TBL] [Abstract][Full Text] [Related]
32. Comparative in vitro activity of sparfloxacin (AT 4140, RP 64206--SPFX) against 275 multiresistant clinical isolates. Giamarellou H; Voutsinas D; Xirouchaki E J Chemother; 1992 Feb; 4(1):12-5. PubMed ID: 1328554 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates. Bassetti M; Dembry LM; Farrel PA; Callan DA; Andriole VT Antimicrob Agents Chemother; 2002 Jan; 46(1):234-8. PubMed ID: 11751142 [TBL] [Abstract][Full Text] [Related]
34. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents. McCarter YS; Mazens-Sullivan MF; Bartlett RC Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507 [TBL] [Abstract][Full Text] [Related]
35. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela. Torres JR Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497 [TBL] [Abstract][Full Text] [Related]
36. Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria. Qadri SM; Ueno Y; Postle G; Tullo D; San Pedro J Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):372-7. PubMed ID: 8394816 [TBL] [Abstract][Full Text] [Related]